Meghan Fitzgerald insider trades

Open-market stock purchases and sales by Meghan Fitzgerald, Director at Roivant Sciences Ltd, from SEC Form 4 filings since Aug 4, 2015.

Recent trades

DateStockTradeValue
Sep 16, 2026ROIV Roivant Sciences LtdBought (not open market)—
Sep 16, 2026ROIV Roivant Sciences LtdBought (not open market)—
Sep 15, 2026ROIV Roivant Sciences LtdSold$187K
Sep 15, 2026ROIV Roivant Sciences LtdSold$16.2K
Sep 10, 2026ROIV Roivant Sciences LtdSold (not open market)$71.4K
May 27, 2026THC Tenet HealthCare CorpBought (not open market)—
May 22, 2026THC Tenet HealthCare CorpSold (not open market)$85.7K
May 22, 2026THC Tenet HealthCare CorpBought (not open market)—
Mar 26, 2026ROIV Roivant Sciences LtdSold$1.9M
Mar 26, 2026ROIV Roivant Sciences LtdBought (not open market)—

Companies traded

  • ROIV Roivant Sciences Ltd: 3 sales, last Sep 16, 2026
  • THC Tenet HealthCare Corp: 1 buy, 3 sales, last May 27, 2026
  • CNCE Concert Pharmaceuticals, Inc: other filings, last Jun 14, 2018
  • CAH Cardinal Health Inc: other filings, last Nov 17, 2015

Get free alerts when Meghan Fitzgerald files a new trade →